CO2 utilization as gas antisolvent for the pharmaceutical micro and nanoparticle production: A review

Abstract

A reduction in particle size improves the solubility and bioavailability of pharmaceuticals. The traditional methods utilized in this regard are associated with problems so the use of supercritical fluid has been highlighted in recent decades. To prepare nanoparticles by employing the gas antisolvent (GAS) technique, a specific amount of solution (solute dissolved in organic solvent) was loaded into a cell in the oven. The supercritical carbon dioxide was injected and dissolved into the organic solvent. Therefore, volume expansion occurred and the solute was precipitated with a new particle size distribution on the filter at the end of the cell. This technique exhibits advantages such as particle size control, solvent-free product, and low-temperature process. Many experimental and modeling research has been conducted to synthesize nano- and microparticles based on the GAS process. The present study seeks to review the effective factors and literature on the GAS technique. All parameters affecting the GAS process including pressure, temperature, antisolvent addition rate, initial soluble concentration, and solvent were investigated. Volume expansion, thermodynamic modeling, and kinetic modeling of the GAS process were reviewed. A comparison was conducted between the advantages and disadvantages of this method with other methods of producing nanoparticles with supercritical fluid.

Keywords

• Gas antisolvent (GAS)
• Particle size
• Experimental
• Modeling
• Nanoparticle